SCHEMBL32678587

SCHEMBL32678587

C[C@@H](c1ccncc1)N(C)C(=O)NCC(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.43
ROCK1 Q13464 2/20 0.43
MTOR P42345 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
CYP2C9 P11712 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32678583 1.00 ROCK2 (0.43) ROCK2ROCK1MTORSMN1; SMN2LMNA
SCHEMBL32678594 1.00 ROCK2 (0.43) ROCK2ROCK1MTORSMN1; SMN2LMNA
SCHEMBL32678592 1.00 ROCK2 (0.43) ROCK2ROCK1MTORSMN1; SMN2LMNA
SCHEMBL32678585 1.00 ROCK2 (0.43) ROCK2ROCK1MTORSMN1; SMN2LMNA
SCHEMBL32678576 0.86 MTOR (0.57) ROCK2ROCK1MTOR
SCHEMBL32678578 0.86 MTOR (0.57) ROCK2ROCK1MTOR
SCHEMBL11177086 0.82 ROCK2 (0.46) ROCK2ROCK1MTORSMN1; SMN2LMNA
SCHEMBL9348326 0.72 ROCK2 (0.43) ROCK2ROCK1MTORSMN1; SMN2MAPT
SCHEMBL28844111 0.72 ROCK2 (0.46) ROCK2ROCK1MTORSMN1; SMN2CYP3A4
SCHEMBL20733241 0.71 SMN1; SMN2 (0.45) ROCK2ROCK1MTORSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260053804-A1 Compositions and Methods for the Restoration of Ciliary Function UNIV YALE (US) 2026-02-26 US claimed
US-20260053804-A1 Compositions and Methods for the Restoration of Ciliary Function UNIV YALE (US) 2026-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260053804-A1 Compositions and Methods for the Restoration of Ciliary Function MTCL3, DYNLL2, CEP170 ROCK2 166/4885ROCK1 282/4885MTOR 385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.